ALCON INC (2U3.DE) Stock Fundamental Analysis

FRA:2U3 • CH0432492467

66.96 EUR
+0.84 (+1.27%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

2U3 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of 2U3 get a neutral evaluation. Nothing too spectacular is happening here. 2U3 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • 2U3 had positive earnings in the past year.
  • 2U3 had a positive operating cash flow in the past year.
  • 2U3 had positive earnings in 4 of the past 5 years.
  • In the past 5 years 2U3 always reported a positive cash flow from operatings.
2U3.DE Yearly Net Income VS EBIT VS OCF VS FCF2U3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.32%, 2U3 is in line with its industry, outperforming 49.21% of the companies in the same industry.
  • The Return On Equity of 2U3 (4.74%) is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 3.94%, 2U3 is not doing good in the industry: 63.49% of the companies in the same industry are doing better.
  • 2U3 had an Average Return On Invested Capital over the past 3 years of 3.01%. This is significantly below the industry average of 9.98%.
  • The 3 year average ROIC (3.01%) for 2U3 is below the current ROIC(3.94%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.32%
ROE 4.74%
ROIC 3.94%
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
2U3.DE Yearly ROA, ROE, ROIC2U3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.28%, 2U3 is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 2U3 has grown nicely.
  • Looking at the Operating Margin, with a value of 13.63%, 2U3 is in the better half of the industry, outperforming 63.49% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 2U3 has grown nicely.
  • 2U3's Gross Margin of 54.26% is in line compared to the rest of the industry. 2U3 outperforms 44.44% of its industry peers.
  • 2U3's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.63%
PM (TTM) 10.28%
GM 54.26%
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
2U3.DE Yearly Profit, Operating, Gross Margins2U3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 2U3 is destroying value.
  • Compared to 1 year ago, 2U3 has more shares outstanding
  • 2U3 has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 2U3 has an improved debt to assets ratio.
2U3.DE Yearly Shares Outstanding2U3.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
2U3.DE Yearly Total Debt VS Total Assets2U3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • 2U3 has an Altman-Z score of 4.07. This indicates that 2U3 is financially healthy and has little risk of bankruptcy at the moment.
  • 2U3 has a better Altman-Z score (4.07) than 74.60% of its industry peers.
  • 2U3 has a debt to FCF ratio of 3.63. This is a good value and a sign of high solvency as 2U3 would need 3.63 years to pay back of all of its debts.
  • The Debt to FCF ratio of 2U3 (3.63) is better than 68.25% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that 2U3 is not too dependend on debt financing.
  • 2U3 has a Debt to Equity ratio of 0.21. This is in the better half of the industry: 2U3 outperforms 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 3.63
Altman-Z 4.07
ROIC/WACC0.84
WACC4.68%
2U3.DE Yearly LT Debt VS Equity VS FCF2U3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B

2.3 Liquidity

  • 2U3 has a Current Ratio of 2.12. This indicates that 2U3 is financially healthy and has no problem in meeting its short term obligations.
  • 2U3 has a Current ratio of 2.12. This is in the better half of the industry: 2U3 outperforms 65.08% of its industry peers.
  • 2U3 has a Quick Ratio of 1.30. This is a normal value and indicates that 2U3 is financially healthy and should not expect problems in meeting its short term obligations.
  • 2U3 has a Quick ratio of 1.30. This is in the better half of the industry: 2U3 outperforms 63.49% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.3
2U3.DE Yearly Current Assets VS Current Liabilites2U3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for 2U3 have decreased by -0.66% in the last year.
  • Measured over the past years, 2U3 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.04% on average per year.
  • 2U3 shows a small growth in Revenue. In the last year, the Revenue has grown by 4.34%.
  • Measured over the past years, 2U3 shows a small growth in Revenue. The Revenue has been growing by 5.71% on average per year.
EPS 1Y (TTM)-0.66%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%-2.47%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%5.5%

3.2 Future

  • Based on estimates for the next years, 2U3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.95% on average per year.
  • Based on estimates for the next years, 2U3 will show a small growth in Revenue. The Revenue will grow by 6.09% on average per year.
EPS Next Y0.91%
EPS Next 2Y6.18%
EPS Next 3Y9.52%
EPS Next 5Y10.95%
Revenue Next Year5.17%
Revenue Next 2Y6.2%
Revenue Next 3Y6.32%
Revenue Next 5Y6.09%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
2U3.DE Yearly Revenue VS Estimates2U3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B
2U3.DE Yearly EPS VS Estimates2U3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 26.47, 2U3 can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of 2U3 indicates a somewhat cheap valuation: 2U3 is cheaper than 61.90% of the companies listed in the same industry.
  • 2U3 is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.97, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 23.12, the valuation of 2U3 can be described as rather expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as 2U3.
  • 2U3's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.96.
Industry RankSector Rank
PE 26.47
Fwd PE 23.12
2U3.DE Price Earnings VS Forward Price Earnings2U3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 2U3 is valued a bit cheaper than 60.32% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, 2U3 is valued a bit cheaper than 65.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.57
EV/EBITDA 15.91
2U3.DE Per share data2U3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 2U3 does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of 2U3 may justify a higher PE ratio.
PEG (NY)29.15
PEG (5Y)2.63
EPS Next 2Y6.18%
EPS Next 3Y9.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. Dividend

5.1 Amount

  • 2U3 has a yearly dividend return of 0.46%, which is pretty low.
  • 2U3's Dividend Yield is comparable with the industry average which is at 1.01.
  • With a Dividend Yield of 0.46, 2U3 pays less dividend than the S&P500 average, which is at 1.84.
Industry RankSector Rank
Dividend Yield 0.46%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 2U3 pays out 15.85% of its income as dividend. This is a sustainable payout ratio.
DP15.85%
EPS Next 2Y6.18%
EPS Next 3Y9.52%
2U3.DE Yearly Income VS Free CF VS Dividend2U3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
2U3.DE Dividend Payout.2U3.DE Dividend Payout, showing the Payout Ratio.2U3.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ALCON INC

FRA:2U3 (2/13/2026, 7:00:00 PM)

66.96

+0.84 (+1.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11
Earnings (Next)03-03
Inst Owners68.39%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap33.46B
Revenue(TTM)10.19B
Net Income(TTM)1.05B
Analysts76
Price Target91.3 (36.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.46%
Yearly Dividend0.22
Dividend Growth(5Y)N/A
DP15.85%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.69%
Min EPS beat(2)2.89%
Max EPS beat(2)4.49%
EPS beat(4)3
Avg EPS beat(4)0.92%
Min EPS beat(4)-4.26%
Max EPS beat(4)4.49%
EPS beat(8)7
Avg EPS beat(8)2.38%
EPS beat(12)9
Avg EPS beat(12)2.81%
EPS beat(16)12
Avg EPS beat(16)4.78%
Revenue beat(2)0
Avg Revenue beat(2)-2.25%
Min Revenue beat(2)-2.97%
Max Revenue beat(2)-1.52%
Revenue beat(4)0
Avg Revenue beat(4)-2.12%
Min Revenue beat(4)-3.43%
Max Revenue beat(4)-0.56%
Revenue beat(8)0
Avg Revenue beat(8)-1.8%
Revenue beat(12)2
Avg Revenue beat(12)-1.03%
Revenue beat(16)4
Avg Revenue beat(16)-0.36%
PT rev (1m)-1.65%
PT rev (3m)-2.21%
EPS NQ rev (1m)0.2%
EPS NQ rev (3m)-6.97%
EPS NY rev (1m)0.13%
EPS NY rev (3m)-0.38%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 26.47
Fwd PE 23.12
P/S 3.9
P/FCF 27.57
P/OCF 19.17
P/B 1.8
P/tB 10.86
EV/EBITDA 15.91
EPS(TTM)2.53
EY3.78%
EPS(NY)2.9
Fwd EY4.33%
FCF(TTM)2.43
FCFY3.63%
OCF(TTM)3.49
OCFY5.22%
SpS17.17
BVpS37.22
TBVpS6.17
PEG (NY)29.15
PEG (5Y)2.63
Graham Number46.03
Profitability
Industry RankSector Rank
ROA 3.32%
ROE 4.74%
ROCE 4.86%
ROIC 3.94%
ROICexc 4.16%
ROICexgc 13.06%
OM 13.63%
PM (TTM) 10.28%
GM 54.26%
FCFM 14.15%
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
ROICexc(3y)3.18%
ROICexc(5y)N/A
ROICexgc(3y)10.24%
ROICexgc(5y)N/A
ROCE(3y)3.72%
ROCE(5y)N/A
ROICexgc growth 3Y2.95%
ROICexgc growth 5Y30.08%
ROICexc growth 3Y10.31%
ROICexc growth 5Y41.26%
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
F-Score5
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 3.63
Debt/EBITDA 1.7
Cap/Depr 48.06%
Cap/Sales 6.2%
Interest Coverage 7.46
Cash Conversion 76.71%
Profit Quality 137.63%
Current Ratio 2.12
Quick Ratio 1.3
Altman-Z 4.07
F-Score5
WACC4.68%
ROIC/WACC0.84
Cap/Depr(3y)77.98%
Cap/Depr(5y)73.14%
Cap/Sales(3y)9.96%
Cap/Sales(5y)10.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.66%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%-2.47%
EPS Next Y0.91%
EPS Next 2Y6.18%
EPS Next 3Y9.52%
EPS Next 5Y10.95%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%5.5%
Revenue Next Year5.17%
Revenue Next 2Y6.2%
Revenue Next 3Y6.32%
Revenue Next 5Y6.09%
EBIT growth 1Y5.55%
EBIT growth 3Y13.34%
EBIT growth 5Y43.18%
EBIT Next Year37.04%
EBIT Next 3Y18.36%
EBIT Next 5Y14.43%
FCF growth 1Y174.48%
FCF growth 3Y104.3%
FCF growth 5Y41.96%
OCF growth 1Y61.62%
OCF growth 3Y15.59%
OCF growth 5Y17.69%

ALCON INC / 2U3.DE FAQ

What is the ChartMill fundamental rating of ALCON INC (2U3.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 2U3.DE.


What is the valuation status of ALCON INC (2U3.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to ALCON INC (2U3.DE). This can be considered as Fairly Valued.


How profitable is ALCON INC (2U3.DE) stock?

ALCON INC (2U3.DE) has a profitability rating of 6 / 10.


How financially healthy is ALCON INC?

The financial health rating of ALCON INC (2U3.DE) is 6 / 10.


Can you provide the dividend sustainability for 2U3 stock?

The dividend rating of ALCON INC (2U3.DE) is 2 / 10 and the dividend payout ratio is 15.85%.